with therapeutic

Mixed neuroendocrine-non-neuroendocrine neoplasms, amphicrine-like carcinoma and related lesions: a review of changes in classification and current concepts.

To trace the historical evolution of gastrointestinal mixed epithelial-neuroendocrine tumour terminology, clarify current diagnostic criteria, histological features and approach to reporting these lesions in accordance with the latest classification of gastrointestinal tumours, a narrative overview was undertaken on mi...

Historical Evolution of Terminology and Current Classification of Neuroendocrine Neoplasms of the Larynx and Mixed Neuroendocrine–Non-Neuroendocrine Neoplasms (MiNENs): A Narrative Review

This is a narrative review that describes the evolution of terminology and classification schemes of neuroendocrine tumors (NETs), neuroendocrine carcinomas (NECs), mixed neuroendocrine–non-neuroendocrine neoplasms (MiNENs), and paragangliomas of the larynx, with the contribution of immunohistochemistry and treatment o...

Immunological Features of Neuroendocrine Neoplasms and Adrenal Tumors

The immunological features of representative neuroendocrine and adrenal tumors (neuroendocrine tumor, neuroendocrine carcinoma, adrenocortical carcinoma, and pheochromocytoma/paraganglioma) are examined, suggesting a potential benefit observed in selected subgroups.

Pancreatic Neuroendocrine Microtumors: Etiology, Diagnostic Criteria, and Differential Diagnosis.

Assessment of somatostatin receptor expression in patients with pulmonary and thymic neuroendocrine neoplasms. First results of a single-center study

Background . Pulmonary and thymic neuroendocrine neoplasms (NENs) are divided into a group of well-differentiated neuroendocrine tumors (NETs), including typical and atypical carcinoids (TC and AC), and a group of poorly differentiated neuroendocrine carcinomas (NECs), including large cell neuroendocrine carcinoma (...

Neuroendocrine Tumors (NETs) of the Larynx

By utilizing the proposed diagnostic criteria for individual types of laryngeal NETs, it is anticipated that more precise knowledge regarding the clinico-pathological characteristics of these exceedingly rare tumors will be obtained, particularly with respect to their biological behavior and prognosis.